Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NPC-11 (Caffeine Citrate) in Apnea of Prematurity
NCT01408173Phase 3Completed
- Sponsor
- Nobelpharma Co., Ltd.
- Start
- Aug 2011
- Primary completion
- Oct 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of caffeine in apnea of prematurity (AOP), sponsored by Nobelpharma Co., Ltd. Primary endpoint: Success rates for controlling of apnea episode in each observation day at Day 10. Started Aug 2011; status: completed.
02
Drugs
caffeine
03
Conditions
apnea of prematurity (AOP)
Beyond the preview
Go deeper on NCT01408173.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01408173.